0001923614-23-000001.txt : 20230412 0001923614-23-000001.hdr.sgml : 20230412 20230412150113 ACCESSION NUMBER: 0001923614-23-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20230412 DATE AS OF CHANGE: 20230412 EFFECTIVENESS DATE: 20230412 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alger Life Sciences Innovation Fund LP CENTRAL INDEX KEY: 0001923614 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-442344 FILM NUMBER: 23815464 BUSINESS ADDRESS: STREET 1: 100 PEARL STREET, 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 212-806-8800 MAIL ADDRESS: STREET 1: 100 PEARL STREET, 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 D/A 1 primary_doc.xml X0708 D/A LIVE 0001923614 Alger Life Sciences Innovation Fund LP 100 PEARL STREET, 27TH FLOOR 27th Floor NEW YORK NY NEW YORK 10004 212-806-8800 DELAWARE None None Limited Partnership true 2022 N/A Alger Alternative Holdings II, LLC 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Promoter General Partner of the Issuer N/A Fred Alger Management, LLC 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Promoter Investment Manager of the Issuer Daniel Cayley Chung 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Executive Officer Director Hal Liebes 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Executive Officer Director Robert Louis Kincel 100 Pearl Street 27th Floor New York NY NEW YORK 10004 Executive Officer Director Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.7 true 0000945621-22-000208 2022-05-20 true true false 500000 Indefinite 12217947 Indefinite Clarification of Item 11: The minimum initial investment amount is $500,000, and the minimum additional investment amount is $250,000, which may be reduced or waived by the General Partner in its sole discretion. false 13 0 0 0 The Investment Manager will receive a management fee as outlined in the Issuer's offering material. false Alger Life Sciences Innovation Fund LP Hal Liebes Hal Liebes Director 2023-04-12